• Chugai has been recognized as a highly sustainable company and ranked second in the world as a pharmaceutical company
• Selected for four consecutive years in the “DJSI World,” comprised of the top six sustainable pharmaceutical companies in the world
• Selected as “DJSI Asia Pacific” for the nineth time for six consecutive years

TOKYO, December 11, 2023 -- Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) announced that the company has been selected for four consecutive years as a constituent of “Dow Jones Sustainability Indices (DJSI) World,” the global version of DJSI, which is the world’s leading ESG investment index. Furthermore, Chugai has been selected as a constituent of “DJSI Asia Pacific,” the Asia-Pacific version, for the nineth time for six consecutive years.

DJSI is a leading ESG index developed by S&P Dow Jones Indices (USA) and is one of the main investment selection criteria for investors worldwide who are interested in corporate sustainability. Companies are selected annually as a constituent based on the sustainability assessment of corporate economic, environmental, and social aspects.

In the pharmaceutical sector of the “DJSI World,” the top six sustainable companies have been selected as constituents, including Chugai. Chugai received the world’s second rating as a sustainable company among global pharmaceutical companies. In total, 321 companies (including 38 Japanese companies) were selected for the DJSI World. Three companies, including Chugai, have been selected for “DJSI Asia Pacific.” Chugai significantly surpassed last year’s scores in areas such as innovation management and occupational health and safety (OHS), and received high marks overall.

The Company’s basic management policy is “creating shared value for Chugai and society” and aims to “realize advanced and sustainable patient-centric healthcare.” Chugai will continue dialogue with the stakeholders and contribute to the developing a sustainable society through our business activities.